The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of pain

被引：15

作者：

Brown, Alan D. ^{[1
]}

Bagal, Sharan K. ^{[1
]}

Blackwell, Paul ^{[2
]}

Blakemore, David C. ^{[4
]}

Brown, Bruce ^{[2
]}

Bungay, Peter J. ^{[3
]}

Corless, Martin ^{[2
]}

Crawforth, James ^{[2
]}

Fengas, David ^{[5
]}

Fenwick, David R. ^{[2
]}

Gray, Victoria ^{[2
]}

Kemp, Mark ^{[2
]}

Klute, Wolfgang ^{[2
]}

Sanz, Laia Malet ^{[2
]}

Miller, Duncan ^{[2
]}

Murata, Yoshihisa ^{[2
]}

Payne, C. Elizabeth ^{[3
]}

Skerratt, Sarah ^{[1
]}

Stevens, Edward B. ^{[3
]}

Warmus, Joseph S. ^{[4
]}

机构：

[1] Pfizer Ltd, Pfizer Med Design, Portway Bldg,Granta Pk, Cambridge CB21 6GS, England

[2] Pfizer Global R&D, Pfizer Med Sci, Sandwich CT13 9FF, Kent, England

[3] Pfizer Ltd, Med Sci, Portway Bldg,Granta Pk, Cambridge CB21 6GS, England

[4] Groton Labs, Pfizer Med Design, Eastern Point Rd, Groton, CT 06340 USA

[5] Concept Life Sci, Discovery Pk,Ramsgate Rd, Sandwich CT13 9FF, Kent, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2019年 / 27卷 / 01期

关键词：

Benzimidazole; PF-06305591; Neuropathic pain; Inflammatory pain; Voltage gated sodium channel; Na(V)1.8; SCN10A; INHIBITORS; MUTATIONS; POTENT;

D O I：

10.1016/j.bmc.2018.12.002

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The voltage gated sodium channel Na(V)1.8 has been postulated to play a key role in the transmission of pain signals. Core hopping from our previously reported phenylimidazole leads has allowed the identification of a novel series of benzimidazole Na(V)1.8 blockers. Subsequent optimization allowed the identification of compound 9, PF-06305591, as a potent, highly selective blocker with an excellent preclinical in vitro ADME and safety profile.

引用

页码：230 / 239

页数：10

共 50 条

[41] Na-channel NaV1.8 as a new selective target for treating atrial arrhythmogenesis
Pabel, Steffen
Ahmad, Shakil
Tirilomis, Petros
Stehle, Thea
Dybkova, Nataliya
Bengel, Philipp
Streckfuss-Boemeke, Katrin
Hasenfuss, Gerd
Maier, Lars
Sossalla, Samuel
INTERNIST, 2019, 60 : S30 - S30
[42] The Changes in Expression of NaV1.7 and NaV1.8 and the Effects of the Inhalation of Their Blockers in Healthy and Ovalbumin-Sensitized Guinea Pig Airways
Kocmalova, Michaela
Kazimierova, Ivana
Barborikova, Jana
Joskova, Marta
Franova, Sona
Sutovska, Martina
MEMBRANES, 2021, 11 (07)
[43] Targeting Voltage Gated Sodium Channels NaV1.7, NaV1.8, and NaV1.9 for Treatment of Pathological Cough
Muroi, Yukiko
Undem, Bradley J.
LUNG, 2014, 192 (01) : 15 - 20
[44] Targeting Voltage Gated Sodium Channels NaV1.7, NaV1.8, and NaV1.9 for Treatment of Pathological Cough
Yukiko Muroi
Bradley J. Undem
Lung, 2014, 192 : 15 - 20
[45] Discovery of selective NaV1.8 inhibitors based on 5-chloro-2-(4,4-difluor- oazepan-1-yl)-6-methyl nicotinamide scaffold for the treatment of pain
Qin, Hui
Wei, Aihuan
Wang, Yunqi
Wang, Linlin
Xu, Haiyan
Zhan, Yan
Tian, Xuechen
Zheng, Yueming
Gao, Zhaobing
Hu, Youhong
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 254
[46] Optogenetic Inhibition of Nav1.8 Expressing Corneal Afferents Reduces Persistent Dry Eye Pain
Mecum, Neal E.
Russell, Rachel
Lee, Jun
Sullivan, Cara
Meng, Ian D.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (14)
[47] Melatonin attenuated chronic visceral pain by reducing Nav1.8 expression and nociceptive neuronal sensitization
Lv, Meng-Dan
Wei, Ying-Xue
Chen, Jian-Peng
Cao, Ming-Yao
Wang, Qian-Liang
Hu, Shufen
MOLECULAR PAIN, 2023, 19
[48] Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8
Lai, J
Gold, MS
Kim, CS
Bian, D
Ossipov, MH
Hunter, JC
Porreca, F
PAIN, 2002, 95 (1-2) : 143 - 152
[49] Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models
Xue, Yaping
Chidiac, Celeste
Herault, Yann
Gaveriaux-Ruff, Claire
NEUROSCIENCE LETTERS, 2021, 753
[50] Additive Antinociceptive Effects of the Selective Nav1.8 Blocker A-803467 and Selective TRPV1 Antagonists in Rat Inflammatory and Neuropathic Pain Models
Joshi, S. K.
Honore, Prisca
Hernandez, Gricelda
Schmidt, Robert
Gomtsyan, Arthur
Scanlo, Marc
Kort, Michael
Jarvis, Michael F.
JOURNAL OF PAIN, 2009, 10 (03): : 306 - 315

← 1 2 3 4 5 →